
Eli Lilly Shocks Wall Street: Global Demand for Weight-Loss Drugs Sends Forecast Soaring!
30.10.2025
0:00
7:38
Eli Lilly has raised its full-year forecast after unprecedented international demand for its hit weight-loss and diabetes drugs, Mounjaro and Zepbound. The pharmaceutical giant’s booming sales and rapid global expansion signal a new era for obesity treatment worldwide.
Get the top 40+ AI Models for $20 at AI Box: https://aibox.ai
AI Chat YouTube Channel: https://www.youtube.com/@JaedenSchafer
Join my AI Hustle Community: https://www.skool.com/aihustle
Więcej odcinków z kanału "Practical: AI & Business News"



Nie przegap odcinka z kanału “Practical: AI & Business News”! Subskrybuj bezpłatnie w aplikacji GetPodcast.







